Against the backdrop of leading vaccine maker Bharat Biotech partnering with Thomas Jefferson University of Philadelphia to develop a new vaccine candidate for COVID-19 invented at Jefferson, it seems the emergency vaccine for COVID-19 would be available latest by January or February next year, says N.K. Ganguly, former Director-General, Indian Council of Medical Research (ICMR).
Speaking to IANS, Ganguly said that most of the vaccine development programmes aim at identifying the genetic code of the spike protein, which has already been identified in this case, that Sars-CoV-2 uses to enter the human cells. In the development of the vaccine, this is used to trigger an immune response against subsequent exposure in people who are vaccinated, he added. "Emergency vaccine will be available for use latest by January or February 2021," said Ganguly.


